IQVIA Services Japan

What IQVIA Services Japan does

IQVIA Services Japan is the Tokyo-based Japanese operating entity of IQVIA Inc. (NYSE:IQV), a global life sciences data, technology, and services company. It delivers an integrated portfolio spanning Research & Development (early-phase trials, Phase IIb/III trials, patient and site-centric solutions, functional services, global laboratories, and R&D consulting), Real World Evidence generation, Commercialization services (HCP engagement, brand strategy, launch management, commercial analytics), Technology Solutions (SaaS suites including Site Suite, Patient Suite, Clinical Trial Financial Suite, Safety Suite, and SmartSolve eQMS/RIM), and Safety & Regulatory Compliance services (pharmacovigilance, regulatory compliance, quality compliance). The underlying platform, IQVIA Connected Intelligence, integrates 64+ petabytes of proprietary healthcare data, 1.2B+ non-identified patient records, and Healthcare-grade AI capabilities — including the proprietary Medical Reasoning LLM (Med-R1 8B), an NLP Platform, and agentic AI co-developed with NVIDIA — to support clinical, commercial, and real-world operations across the product lifecycle.

The company serves pharmaceutical manufacturers, emerging biopharma, consumer health, generics, medtech, payers, providers, and government/public health organizations in Japan and across the broader 100+ country global footprint, with named enterprise customers including Bayer, Boehringer Ingelheim, Sanofi, Alnylam, and government engagements such as India's NITI Aayog. Revenue mechanics blend professional services engagements (clinical trials, consulting, real-world evidence, commercialization projects) with recurring SaaS subscriptions for technology platforms. Go-to-market is primarily direct enterprise field sales with consultative selling, supplemented by cloud marketplace distribution (Snowflake Data Marketplace for OneKey and other data assets) and strategic partnerships (NVIDIA, Veeva, Boehringer Ingelheim, Bespoke Gene Therapy Consortium). Pricing is quote-based and tailored to enterprise scope; specific unit pricing is not publicly disclosed.

The Japan entity operates within a parent organization listed on the NYSE, with three wholly-owned subsidiaries (IQVIA Biotech, IQVIA Laboratories, IQVIA Consulting and Information Services India Pvt. Ltd.), FedRAMP Authorization and ISO 27001 certification supporting regulated workloads, and a 2026 designation as a Fortune World's Most Admired Company for the ninth consecutive year. Strategic positioning emphasizes end-to-end coverage from molecule to market, leveraging scale (85% of global pharma sales tracked), domain specialization (84% of FDA-approved oncology drugs 2016-2024 involved IQVIA; 95% of hematology drugs), and proprietary data assets as durable differentiators against fragmented point-solution competitors.

Name

IQVIA Services Japan

Legal name

IQVIA Inc.

Website

https://iqvia.com

Company type

Public

Founded year

1982

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

IQVIA Services Japan is the Japanese subsidiary of IQVIA Inc., providing clinical research, real-world evidence, commercialization, AI-driven analytics, and technology platforms to pharmaceutical, biotech, medtech, and healthcare organizations in Japan.

Ownership category

akta.pro rank

Product category

Life Sciences Research & Analytics Services

NAICS

Professional, Scientific, and Technical Services (541), Computer Systems Design and Related Services (54151), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Misc Health & Allied Services, Nec (8090), Services-Health Services (8000)

akta.pro primary industry

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

akta.pro secondary industries

Regulatory Information Management (RIM) & Submission Publishing Software (HLAGAJAL), De-identification, Tokenization & Privacy-Preserving Data Platforms (HLACAIAK), Health Information Exchange & Public Health Data Integration (HLAJAJAD)

Keywords

• Clinical research services
• Real-world evidence
• Pharmaceutical data analytics
• Pharmacovigilance compliance
• Life sciences technology

Headquarters

HQ city

Tokyo

HQ country

Japan

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Research & Development Services: Clinical trial services including early phase trials, Phase IIb/III trials, patient and site centric solutions, functional services, global laboratories, and R&D consulting for pharmaceutical and biotech companies
2. Real World Evidence Solutions: Generation and dissemination of real-world evidence for clinical, regulatory, and commercial questions including health economics, market access, and regulatory submissions
3. Commercialization Services: Commercial effectiveness solutions including HCP engagement, patient engagement, brand strategy, launch management, and commercial analytics for pharmaceutical companies
4. Technology Solutions: SaaS and technology platforms including Site Suite, Patient Suite, Clinical Trial Financial Suite, Safety Suite, and Quality Management platforms for clinical operations
5. Safety & Regulatory Compliance Services: End-to-end compliance services including pharmacovigilance, regulatory compliance, quality compliance, and medical information across the product lifecycle

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

IQVIA Services Japan delivers end-to-end life sciences solutions spanning clinical research and development, real-world evidence generation, commercialization support, and safety/regulatory compliance services, complemented by a suite of proprietary SaaS technology platforms such as the IQVIA AI Platform, IQVIA Vigilance Platform, SmartSolve eQMS, Site Suite, Patient Engagement Suite, and Clinical Trial Financial Suite. The Tokyo operation serves pharmaceutical manufacturers, biotech firms, government health agencies, and healthcare payers across Japan and the broader Asia Pacific region, drawing on the parent group's proprietary healthcare data assets covering 64+ petabytes and 1.2B+ patient records.

Product overview

IQVIA is a global life sciences data, technology, and services company offering an integrated portfolio of clinical, commercial, and real-world evidence solutions. The core platform, IQVIA Connected Intelligence, unifies proprietary healthcare data, advanced AI/ML capabilities, and analytics to address challenges across the product lifecycle. Key products include IQVIA AI Platform (IQVIA.ai) and Healthcare-grade AI for enterprise AI deployment; IQVIA Vigilance Platform and SmartSolve eQMS/RIM for safety, regulatory, and quality compliance; IQVIA Site Suite, Patient Suite, and Clinical Trial Financial Suite for clinical operations; and Field Force Agent, Global Market Insights Agent, and Orchestrated Analytics for commercial optimization. Real-world data products include Health Data Apps & AI, IQVIA NLP Platform, and OneKey HCP reference data. The company leverages NVIDIA collaboration for AI agent development and offers data access via Snowflake and cloud partnerships.

Differentiator

Problem solved

Functional benefit

Brands

• IQVIA Biotech: Full-service clinical development solutions with specialized, dedicated teams for biotech companies
• IQVIA AI
• IQVIA Connected Intelligence
• IQVIA Healthcare-grade AI
• IQVIA Institute
• IQVIA Vigilance Platform
• IQVIA OneKey
• IQVIA SmartSolve
• IQVIA Orchestrated Clinical Trials

Products and services

• IQVIA AI Platform (IQVIA.ai) Enterprise AI platform that enables life sciences organizations to work efficiently, make better decisions, and scale AI responsibly across clinical, commercial, and real-world operations. Targeted at pharmaceutical manufacturers, biotech, and healthcare enterprises.
• IQVIA Healthcare-grade AI AI capability engineered specifically for life sciences to meet higher levels of precision, speed, and trust in clinical, commercial, and real-world operations. Built in collaboration with NVIDIA. Targeted at enterprise life sciences clients.
• IQVIA Medical Reasoning LLM (Med-R1 8B) Large language model built specifically to empower healthcare and life science organizations, enhance decision-making, and transform patient outcomes. Targeted at healthcare and life science enterprises.
• IQVIA Vigilance Platform Pharmacovigilance platform powered by AI and human expertise, delivering real-time safety insights and global compliance for pharmaceutical and biotech companies.
• SmartSolve eQMS Enterprise quality management system enhancing quality and improving compliance across the full product lifecycle. Targeted at life sciences manufacturers with global quality obligations.
• SmartSolve RIM Regulatory information management system for streamlining global QA/RA processes with AI-enabled capabilities. Targeted at pharmaceutical and biotech regulatory affairs teams.
• IQVIA NLP Platform Advanced natural language processing platform extracting insights at scale from unstructured text for life sciences research and commercial applications.
• IQVIA Field Force Agent AI-powered agentic assistant helping life sciences field teams plan and execute high-impact, compliant HCP engagements with real-time insights. Targeted at pharmaceutical and biotech commercial teams.
• IQVIA Global Market Insights (GMI) Agent Agentic AI providing a unified view of the global market landscape, analyzing market shifts using real-time HCP sentiment, and optimizing launch strategies and competitive intelligence. Targeted at life sciences commercial and brand teams.
• IQVIA Patient Experience Platform Platform delivering personalized, technology-enabled experiences that improve patient satisfaction, adherence, and outcomes. Targeted at pharmaceutical manufacturers and patient support programs.
• IQVIA Site Suite Clinical trial technology suite increasing transparency, improving communications, and reducing administrative burden across the trial lifecycle for sponsors, CROs, and investigator sites.
• IQVIA Patient Engagement Suite Integrated technology solution improving patient operations, elevating experience, and driving better patient outcomes in clinical trials. Targeted at sponsors and CROs running patient-centric studies.
• IQVIA Clinical Trial Financial Suite AI-powered platform unifying budgeting, contracting, forecasting, and payments for streamlined clinical trial financial management. Targeted at sponsors, CROs, and investigator sites.
• IQVIA Safety Suite AI-powered automation combined with global expertise and real-time safety insights for streamlining pharmacovigilance. Targeted at pharmaceutical safety and regulatory teams.
• IQVIA Orchestrated Analytics Analytics platform connecting insights, technology, and expertise to maximize asset value across the product lifecycle. Targeted at life sciences commercial and brand teams.
• IQVIA Health Data Apps & AI Platform providing access to real-world data discovery with the largest agnostic health data catalog for life sciences research. Targeted at sponsors, payers, and research organizations needing real-world evidence.
• IQVIA Biotech Full-service clinical development offering with specialized, dedicated teams tailored to the needs of emerging and established biotech companies across the asset lifecycle.
• Research & Development Services End-to-end clinical research services covering early phase trials, Phase IIb/III trials, patient- and site-centric solutions, functional services, global laboratories, and R&D consulting. Targeted at pharmaceutical manufacturers and biotech companies.
• Real World Evidence Solutions Generation and dissemination of real-world evidence addressing clinical, regulatory, and commercial questions, including health economics, market access, and regulatory submissions. Targeted at pharma, biotech, payers, and regulators.
• Commercialization Services Commercial effectiveness solutions covering HCP engagement, patient engagement, brand strategy, launch management, and commercial analytics for pharmaceutical manufacturers and biotech companies.
• Safety & Regulatory Compliance Services End-to-end compliance services including pharmacovigilance, regulatory compliance, quality compliance, and medical information across the product lifecycle. Targeted at pharma and biotech regulatory and safety teams.

Quantifiable outcome

• 46% faster clinical trial site identification
• +4 more outcomes

Named customers5 records

Segments8 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability11 records

Feature8 records

Partnerships

Four partnerships are on record, tiered core and strategic.

• Boehringer IngelheimcoreStrategic or Co-development Partner · 1 January 2026Strategic long-term global commercial data foundation transformation collaboration announced January 2026. This represents a major data infrastructure partnership to support Boehringer Ingelheim's commercial operations.
• VeevacoreStrategic or Co-development Partner · 1 August 2025IQVIA and Veeva announced long-term clinical and commercial partnerships and resolution of all disputes. This partnership enables collaboration across clinical and commercial operations for life sciences companies.
• NVIDIAcoreTechnology or Integration · 1 January 2025IQVIA partnering with NVIDIA to accelerate Healthcare-grade AI through collaboration that creates new ways for customers to accelerate their efforts to improve patient outcomes. The collaboration involves custom-built AI agents using NVIDIA technology designed to enhance workflows and accelerate insights for life sciences.
• Bespoke Gene Therapy Consortium (BGTC)strategicStrategic or Co-development Partner · 1 April 2024IQVIA participates in the Bespoke Gene Therapy Consortium's regulatory playbook initiative, collaborating with industry and nonprofit partners to develop standardized platform-based approaches and streamline navigation of the regulatory pathway for rare diseases and cell and gene therapies.

Scale indicators19 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Medidata (Dassault Systèmes): Clinical trial technology platform offering Rave EDC, CTMS, eCOA, and AI-driven trial analytics. Medidata competes head-to-head with IQVIA's clinical operations suite across pharma and biotech sponsors.
• Veeva Systems: Cloud-native life sciences platform spanning CRM, CTMS, eTMF, and quality/regulatory. Veeva directly competes with IQVIA's Site Suite, Patient Suite, SmartSolve, and commercial effectiveness products and recently entered a long-term partnership with IQVIA.
• Charles River Laboratories: Provides CRO services, discovery and safety assessment, and manufacturing solutions to pharma and biotech. Overlaps with IQVIA's R&D, Functional Services, and Global Laboratories offerings, particularly in early-phase and preclinical work.
• PPD (Thermo Fisher Scientific): Clinical research and laboratory services business within Thermo Fisher. PPD competes with IQVIA in clinical trial management, central labs, and real-world evidence for global pharma customers.
• Syneos Health: Contract research organization and commercial solutions provider to biopharma. Syneos competes with IQVIA across clinical development and commercialization services for both large pharma and emerging biopharma customers.
• Parexel International: Global CRO providing Phase I–IV clinical research, real-world evidence, and regulatory services. Parexel is a direct alternative to IQVIA's full-service clinical development portfolio for biopharma sponsors.
• ICON plc: Global clinical research organization offering Phase I–IV trial services, labs, and data solutions to pharma and biotech. ICON is one of the closest direct competitors to IQVIA's R&D services and real-world evidence businesses.

Emerging players

• Clarivate: Data and analytics company offering life sciences intelligence, regulatory, and IP solutions. Clarivate overlaps with IQVIA's real-world evidence and healthcare data offerings while focusing on subscription-based intelligence products.

Broad incumbents

• Oracle Health Sciences (Oracle): Provides EDC, clinical trial management, and real-world data platforms as part of Oracle's broader enterprise software portfolio. Oracle competes with IQVIA in clinical operations technology and broader pharma data infrastructure.
• Labcorp: Diagnostics and clinical laboratory services provider with biopharma development services. Labcorp overlaps with IQVIA's central labs and biomarker services and serves many of the same pharmaceutical customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xtwitter.com/IQVIA
• Facebookfacebook.com/IQVIA
• LinkedInlinkedin.com/company/iqvia

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IQVIA Services Japan